These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33314803)
1. Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors. Yoshinaga K; Sadahira T; Maruyama Y; Mitsui Y; Iwata T; Wada K; Araki M; Watanabe T; Nasu Y Investig Clin Urol; 2021 Jan; 62(1):47-55. PubMed ID: 33314803 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the predictive value among inflammation-based scoring systems for bleomycin pulmonary toxicity in patients with germ cell tumors. Maruyama Y; Sadahira T; Araki M; Mitsui Y; Wada K; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y Int J Urol; 2019 Aug; 26(8):813-819. PubMed ID: 31115106 [TBL] [Abstract][Full Text] [Related]
3. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783 [TBL] [Abstract][Full Text] [Related]
4. Novel immunological and nutritional-based prognostic index for gastric cancer. Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer. Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247 [TBL] [Abstract][Full Text] [Related]
6. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. He CB; Lin XJ PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523 [TBL] [Abstract][Full Text] [Related]
8. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma. Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304 [TBL] [Abstract][Full Text] [Related]
9. Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers. Ogul A; Kidi MM; Buyuksimsek M J Gastrointest Cancer; 2021 Mar; 52(1):294-299. PubMed ID: 32495108 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer. Zhang W; Liu K; Ye B; Liang W; Ren Y Cancer Med; 2018 Jan; 7(1):105-113. PubMed ID: 29193777 [TBL] [Abstract][Full Text] [Related]
11. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease. Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J Front Immunol; 2021; 12():691364. PubMed ID: 34248983 [TBL] [Abstract][Full Text] [Related]
12. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Yamada S; Fujii T; Yabusaki N; Murotani K; Iwata N; Kanda M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Medicine (Baltimore); 2016 May; 95(18):e3582. PubMed ID: 27149487 [TBL] [Abstract][Full Text] [Related]
13. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients. Ma C; Yu R; Li J; Guo J; Xu J; Wang X; Liu P J Surg Oncol; 2022 Mar; 125(4):754-765. PubMed ID: 34811745 [TBL] [Abstract][Full Text] [Related]
14. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy. Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323 [TBL] [Abstract][Full Text] [Related]
15. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
16. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma. Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment low prognostic nutritional index and low albumin-globulin ratio are predictive for overall survival in nasopharyngeal cancer. Gundog M; Basaran H Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3221-3230. PubMed ID: 31401760 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study. Kier MG; Lauritsen J; Mortensen MS; Bandak M; Andersen KK; Hansen MK; Agerbaek M; Holm NV; Dalton SO; Johansen C; Daugaard G Eur Urol; 2017 Feb; 71(2):290-298. PubMed ID: 27649970 [TBL] [Abstract][Full Text] [Related]
19. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604). Cafferty FH; White JD; Shamash J; Hennig I; Stenning SP; Huddart RA; Eur J Cancer; 2020 Mar; 127():139-149. PubMed ID: 32007714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]